Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Arcturus Therapeutics Holdings Inc
(NQ:
ARCT
)
15.60
-0.24 (-1.52%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Arcturus Therapeutics Holdings Inc
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Arcturus Therapeutics to Participate in Upcoming Investor Conferences
August 31, 2026
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
August 19, 2026
Via
Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
↗
August 19, 2026
Via
Chartmill
Arcturus (ARCT) Q2 2026 Earnings Call Transcript
↗
August 13, 2026
Regaining vaccine rights and advancing rare disease programs toward key 2026 milestones.
Via
The Motley Fool
Topics
Earnings
Arcturus Therapeutics Holdings (NASDAQ:ARCT) Q1 2026 Results: Revenue Miss Weighs on Sentiment as Pipeline Advances
↗
May 07, 2026
Via
Chartmill
Arcturus Therapeutics (NASDAQ:ARCT) Stock Falls After Q4 2025 Revenue Miss
↗
March 03, 2026
Via
Chartmill
Arcturus Therapeutics Eyes Phase III CF Call, OTC Data as Vaccine Funds Pipeline
↗
August 11, 2026
Arcturus Therapeutics (NASDAQ:ARCT) is positioning its mRNA platform around two rare-disease programs targeting cystic fibrosis and ornithine transcarbamylase deficiency, while its vaccine business is...
Via
MarketBeat
Arcturus Therapeutics Q2 Earnings Call Highlights
↗
August 06, 2026
Arcturus Therapeutics (NASDAQ:ARCT) reported progress across its rare-disease pipeline during the second quarter of 2026, completed enrollment and dosing in its Phase II ornithine transcarbamylase...
Via
MarketBeat
Topics
Earnings
Arcturus Therapeutics Announces Second Quarter 2026 Financial Results and Pipeline Progress
August 06, 2026
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026
July 28, 2026
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference
July 20, 2026
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Thursday's session: gap up and gap down stocks
↗
July 02, 2026
Via
Chartmill
Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis
July 02, 2026
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics Highlights mRNA Pipeline, CF Data and Vaccine Expansion at Jefferies
↗
June 05, 2026
Arcturus Therapeutics (NASDAQ:ARCT) President and CEO Joseph Payne outlined the company’s messenger RNA programs, vaccine approvals and upcoming clinical milestones during a presentation at the...
Via
MarketBeat
Arcturus Therapeutics to Present at 2026 Jefferies Global Healthcare Conference
May 26, 2026
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus (ARCT) Q1 2026 Earnings Call Transcript
↗
May 08, 2026
Arcturus (ARCT) Q1 2026 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Get insights into the top gainers and losers of Thursday's after-hours session.
↗
May 07, 2026
Via
Chartmill
Arcturus Therapeutics Announces First Quarter 2026 Financial Results and Pipeline Progress
May 07, 2026
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026
April 27, 2026
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
BioMedNewsBreaks — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial Highlighting Biotech’s Shift Toward Science-Driven Asset Valuation
April 20, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech
April 20, 2026
Via
Investor Brand Network
When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech
April 20, 2026
From
BioMedWire
Via
GlobeNewswire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
↗
March 25, 2026
The widely followed investor has been buying stocks trading well below their all-time highs.
Via
The Motley Fool
These Are the Only 3 Stocks That Cathie Wood Bought Last Week
↗
March 23, 2026
The growing investing icon was skimpy on her purchases last week, making the names she did buy that much more interesting.
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
Arcturus Therapeutics to Attend Upcoming Investor Conference
March 05, 2026
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus (ARCT) Q4 2025 Earnings Call Transcript
↗
March 03, 2026
Arcturus (ARCT) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Lawsuit
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Pipeline Progress
March 03, 2026
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics to Report Fourth Quarter and Fiscal Year 2025 Financial Results and Provide Corporate Update on March 3, 2026
February 17, 2026
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 08, 2026
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics to Attend Upcoming Investor Conference
November 24, 2025
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
